Literature DB >> 22863816

In vivo confocal microscopy of the cornea in Morquio syndrome.

S Stewart, C N J McGhee, D V Patel.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22863816      PMCID: PMC3470058          DOI: 10.1038/eye.2012.155

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  In vivo microstructural analysis of the cornea in Scheie's syndrome.

Authors:  Christina N Grupcheva; Jennifer P Craig; Charles N J McGhee
Journal:  Cornea       Date:  2003-01       Impact factor: 2.651

2.  In vivo microstructural analysis of the cornea in Maroteaux-Lamy syndrome.

Authors:  Dipika V Patel; Judy Y F Ku; Brian Kent-Smith; Charles N J McGhee
Journal:  Cornea       Date:  2005-07       Impact factor: 2.651

3.  Morquio syndrome: electron microscopic findings.

Authors:  T Leslie; M A R Siddiqui; D A Aitken; C M Kirkness; W R Lee; A I Fern
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

4.  Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A).

Authors:  M Iwamoto; Y Nawa; I H Maumenee; J Young-Ramsaran; R Matalon; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Ocular changes in mucopolysaccharidosis IV A (Morquio A syndrome) and long-term results of perforating keratoplasty.

Authors:  B Käsmann-Kellner; J Weindler; B Pfau; K W Ruprecht
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

  5 in total
  2 in total

1.  In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography Findings in Two Cases with Mucopolysaccharidoses

Authors:  Yalçın Karaküçük; Banu Bozkurt; Merve Şahin; Süleyman Okudan
Journal:  Turk J Ophthalmol       Date:  2020-06-27

Review 2.  Mucopolysaccharidosis: A broad review.

Authors:  Ritu Nagpal; Ram Bharos Goyal; K Priyadarshini; Seema Kashyap; Mohita Sharma; Rajesh Sinha; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.